Vanberra Signal

Saphetor

Curated by Signal

Developer of platform for automated next-gen sequencing analysis

Overview

Saphetor develops technology platforms for automated next-gen sequencing analysis. Its flagship product is the Thalia suite, which uses proprietary algorithms to allow healthcare providers to explore variant annotations curated from several databases and create customized reports for diagnosing patients. In addition, Saphetor also gives interpretation support from qualified molecular genetics for clinicians.

Key facts

Founded
2014

Business model

Contact

Open roles

16 roles
  • Senior DevOps Engineer

    Greece · On-site · Volunteer

  • Application Scientist, Clinical Genomics

    Poland · On-site · Volunteer

  • Application Scientist, Bioinformatics

    Philippines · On-site · Volunteer

+ 13 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of AI and mass spectrometry-based platform for personalized medicine

    Life Sciences TechnologyRisch Rotkreuz, Switzerland
  • IVD products for diabetes and women health

    Life Sciences TechnologyFrick, Switzerland
  • Developer of automated solutions for pharmaceutical testing

    Life Sciences TechnologyAesch, Switzerland

About Saphetor

What does Saphetor do?

Saphetor develops technology platforms for automated next-gen sequencing analysis.

Where is Saphetor headquartered?

Saphetor is headquartered in Lausanne, Switzerland.

When was Saphetor founded?

Saphetor was founded in 2014.

Which sector is Saphetor in?

Saphetor operates in Life Sciences Technology.

Who are Saphetor's competitors?

Companies similar to Saphetor include Deep Breath Intelligence, Lobeck Medical, and SOTAX.

Is Saphetor hiring?

Yes. Saphetor has 16 open roles listed on Vanberra Signal.